(Q44364949)

English

Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Casper G. Schalkwijk

5

object named as

Schalkwijk C

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Vermeulen EG

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Rauwerda JA

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

van den Berg M

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

de Jong SC

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Twisk JW

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Stehouwer CD

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

European Journal of Clinical Investigation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

209-215

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Association between albumin:creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Endothelial dysfunction and pathogenesis of diabetic angiopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Features of endothelial dysfunction in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01135.X

21 January 2018

Identifiers

10.1046/J.1365-2362.2003.01135.X

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44364949&oldid=2020118298"